Pharmaceutical

Using Acceleration Levers to Expedite Late Phase CMC Programs for Therapeutic Proteins, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how to optimize timelines and expedite the market readiness of therapeutic proteins using acceleration levers.…

2 months ago

Biomarker-Driven Therapy Launch Strategies for Global Success, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how to launch biomarker-driven therapy with global access and diagnostic success. Attendees will learn how…

2 months ago

Avantor® Unveils Next-Generation Sterile Sampling Platform and PUPSIT Assemblies

Integrated sterile sampling and PUPSIT solutions streamline bioprocessing, enhance flexibility, and reduce risk while accelerating in-process decisions RADNOR, Pa., Oct.…

2 months ago

Google Cloud to Host Second-Annual Cancer AI Symposium in New York City

Leading organizations, researchers, clinicians, and venture capital firms converge to accelerate AI-driven innovation across the cancer continuum NEW YORK, Oct.…

2 months ago

MOOV Expands to Los Angeles With Acquisition of RenewMe

Physician-led wellness brand brings its evidence-based longevity and recovery model to downtown LA. LOS ANGELES, CA / ACCESS Newswire /…

2 months ago

AGFA HealthCare at RSNA 2025: Empowering Clinicians. Elevating Enterprise Imaging

At this year's RSNA 2025 Annual Meeting (November 30 - December 4, McCormick Place, Booth #2565), AGFA HealthCare will highlight…

2 months ago

Medical Care Technologies Inc. (OTC Pink:MDCE) Ranked #1 on InvestorHub Breakout Boards as Company Expands Across Technology and Collectibles Divisions

MESA, ARIZONA / ACCESS Newswire / October 30, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), a diversified holding company…

2 months ago

Dogwood Therapeutics to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

ATLANTA, GA / ACCESS Newswire / October 30, 2025 / Dogwood Therapeutics, Inc. (Nasdaq:DWTX) (the "Company"), a development‐stage biotechnology company…

2 months ago

Entero’s Reinvention Gives the Grid, AI, and Investors Exactly What They’re After: Power and Value (NASDAQ: ENTO)

BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics (NASDAQ:ENTO) has just made one of the…

2 months ago

Moleculin to Highlight its Ongoing Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial at the 14th Annual Acute Leukemia Meeting

HOUSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company…

2 months ago